CD40 is a potential marker of favorable prognosis in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
| Image |  |
|---|---|
| Description | scientific article published in September 2010 |
| Author/s |
author: Mats Jerkeman Sirpa Leppä |
| Publication date | September 1, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |